Sphingosine 1-phosphate lyase expressed in pulmonary epithelial cells potentiates host innate defenses and alleviates influenza pathogenicity in mice

Abstract

Influenza viruses circulate in humans, causing a substantial burden on global health. Investigation of influenza-host interactions could identify host factors that regulate influenza pathogenicity. Sphingosine 1-phosphate (S1P) is a bioactive lipid mediator and regulates crucial cellular processes. S1P lyase (SPL), an enzyme that mediates S1P degradation, was shown to display anti-influenza activity in a cell culture system. Here, we constructed a mouse model to demonstrate the antiviral function of SPL in respiratory epithelial cells during influenza in vivo. Deletion of SPL from lung epithelial cells exacerbated influenza-induced weight loss and mortality. Influenza virus began to propagate more effectively in the absence of SPL at the innate immune stage. Increased virus titers were sustained during influenza and associated with enhanced accumulation of multiple immune cell types in the lungs. Single-cell RNA sequencing was conducted to further define the function of SPL in lung epithelial cells. SPL deletion increased the proportion of alveolar type 1 (AT1) cells compared to alveolar type 2 (AT2) cells with alteration of the related signaling pathways, suggesting a role of SPL in AT1/AT2 programming. Importantly, host innate defense pathways were changed in SPL-deficient lung epithelial cells upon infection, which corroborates the antiviral function of SPL. This study elucidates the host protective function of SPL in lung epithelial cells during influenza and provides gene signature profiles critical for SPL-mediated alleviation of influenza pathogenicity. The findings may contribute to development of host-directed therapeutics to better control influenza.